Table 2.
Homing of Injected Human PBMNCs in Lung, Spleen, and Bone Marrow.
| IRI Model | Sham | |||
|---|---|---|---|---|
| Time after Cell Injection | 24 h | 48 h | 7 d | 24 h |
| Lung | ||||
| QQc PBMNCs group | 38.9 ± 9.9 | 9.3 ± 1.3 | 13.4 ± 2.7 | 11.3 ± 2.3 |
| Non-QQc PBMNCs group | 140.5 ± 15.9* | 133.3 ± 15.9* | 14.8 ± 4.6* | ND |
| Spleen | ||||
| QQc PBMNCs group | 157.8 ± 29.5 | 74.6 ± 15.2 | 28.9 ± 6.0 | 29.3 ± 4.4 |
| Non-QQc PBMNCs group | 478.3 ±15.7* | 541.9 ± 20.6* | 379.6 ± 87.3* | ND |
| Bone marrow | ||||
| QQc PBMNCs group | 19.5 ± 3.1 | 2.5 ± 0.8 | 1.3 ± 0.5 | 3.3 ± 1.7 |
| Non-QQc PBMNCs group | 132.2 ± 3.8* | 140.1 ± 12.1* | 78.8 ± 32.3* | ND |
Abbreviations: PBMNC, peripheral blood mononuclear cell; IRI, ischemia reperfusion injury; QQc, quality and quantity control, ND, not done.
*p < 0.05 vs. QQc PBMNCs group at same time points.